Latest Breaking News On - Lisata therapeutics daily - Page 1 : comparemela.com

Lisata Therapeutics (LSTA) Buy Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Lisata Therapeutics (NASDAQ:LSTA – Free Report) in a research note published on Tuesday morning, Benzinga reports. The firm currently has a $15.00 target price on the stock. Lisata Therapeutics Price Performance LSTA stock opened at $2.96 on Tuesday. Lisata Therapeutics has a 1-year low of $1.95 […]

Lisata therapeutics incCapital managementLisata therapeutics company profileLisata therapeuticsFree reportGet free reportLisata therapeutics daily

Lisata Therapeutics (NASDAQ:LSTA) Stock Rating Reaffirmed by HC Wainwright

Lisata Therapeutics (NASDAQ:LSTA – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $15.00 price objective on the stock. HC Wainwright’s price objective suggests a potential upside of 431.12% from the stock’s previous close. […]

Capital managementLisata therapeutics incSecurities exchange commissionLisata therapeutics company profileLisata therapeuticsGet free reportFree reportLisata therapeutics daily

Lisata Therapeutics (LSTA) to Release Earnings on Thursday

Lisata Therapeutics (LSTA) to Release Earnings on Thursday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Lisata therapeutics company profileLisata therapeutics incLisata therapeuticsGet free reportLisata therapeutics daily

Lisata Therapeutics (LSTA) Set to Announce Quarterly Earnings on Thursday

Lisata Therapeutics (LSTA) Set to Announce Quarterly Earnings on Thursday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Lisata therapeutics incLisata therapeuticsGet free reportLisata therapeutics daily

Lisata Therapeutics (NASDAQ:LSTA) Given Buy Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Lisata Therapeutics (NASDAQ:LSTA – Free Report) in a report released on Thursday, Benzinga reports. HC Wainwright currently has a $15.00 price target on the stock. Lisata Therapeutics Price Performance Shares of LSTA opened at $2.65 on Thursday. The firm has a market cap of $22.02 million, […]

Capital managementLisata therapeutics company profileLisata therapeutics incLisata therapeuticsFree reportGet free reportLisata therapeutics dailyNasdaq lstaReiterated ratingHc wainwright